Synchron completed a $10 million Series A round, which will bankroll a first-in-human trial of its implantable device designed to interpret signals from the brain so paralyzed patients can control ...

- New feature includes AI-driven emotion and language predictions for users in real-time, hands-free without the need for eye tracker or voice control NEW YORK--(BUSINESS WIRE)--Synchron, the ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Elon Musk has approached brain chip implant developer Synchron Inc about a potential investment as his own company Neuralink plays catch-up in the race to connect the human brain directly to machines, ...

New York | The private investment vehicles of billionaires Bill Gates and Jeff Bezos have invested in Australia’s New York-based brain-computer interface company, Synchron, a leading competitor to ...

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

Aug 19 (Reuters) - Elon Musk has approached brain chip implant developer Synchron Inc about a potential investment as his own company Neuralink plays catch-up in the race to connect the human brain ...